Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $5.00 billion. The enterprise value is $7.38 billion.
| Market Cap | 5.00B |
| Enterprise Value | 7.38B |
Important Dates
The next confirmed earnings date is Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Aug 14, 2026 |
Share Statistics
SBRA has 255.46 million shares outstanding. The number of shares has increased by 5.18% in one year.
| Current Share Class | 255.46M |
| Shares Outstanding | 255.46M |
| Shares Change (YoY) | +5.18% |
| Shares Change (QoQ) | -1.44% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 103.73% |
| Float | 251.34M |
Valuation Ratios
The trailing PE ratio is 74.79 and the forward PE ratio is 27.45. SBRA's PEG ratio is 3.79.
| Price/FFO Ratio | 18.94 |
| Price/AFFO Ratio | 12.87 |
| PE Ratio | 74.79 |
| Forward PE | 27.45 |
| PS Ratio | 5.78 |
| Forward PS | 5.07 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.45 |
| PEG Ratio | 3.79 |
Enterprise Valuation
| EV / Earnings | 112.83 |
| EV / Sales | 8.55 |
| EV / EBITDA | 20.00 |
| EV / EBIT | 44.85 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.96.
| Current Ratio | 3.57 |
| Quick Ratio | 3.25 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 7.11 |
| Debt / FCF | n/a |
| Interest Coverage | 1.42 |
Financial Efficiency
Return on equity (ROE) is 2.39% and return on invested capital (ROIC) is 2.94%.
| Return on Equity (ROE) | 2.39% |
| Return on Assets (ROA) | 1.90% |
| Return on Invested Capital (ROIC) | 2.94% |
| Return on Capital Employed (ROCE) | 3.05% |
| Weighted Average Cost of Capital (WACC) | 6.47% |
| Revenue Per Employee | $14.89M |
| Profits Per Employee | $1.13M |
| Employee Count | 58 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $2.13 million in taxes.
| Income Tax | 2.13M |
| Effective Tax Rate | 3.16% |
Stock Price Statistics
The stock price has increased by +7.18% in the last 52 weeks. The beta is 0.62, so SBRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +7.18% |
| 50-Day Moving Average | 19.96 |
| 200-Day Moving Average | 19.97 |
| Relative Strength Index (RSI) | 51.18 |
| Average Volume (20 Days) | 2,364,958 |
Short Selling Information
The latest short interest is 19.92 million, so 7.80% of the outstanding shares have been sold short.
| Short Interest | 19.92M |
| Short Previous Month | 21.02M |
| Short % of Shares Out | 7.80% |
| Short % of Float | 7.93% |
| Short Ratio (days to cover) | 8.16 |
Income Statement
In the last 12 months, SBRA had revenue of $863.77 million and earned $65.44 million in profits. Earnings per share was $0.26.
| Revenue | 863.77M |
| Gross Profit | 434.20M |
| Operating Income | 164.63M |
| Pretax Income | 67.36M |
| Net Income | 65.44M |
| EBITDA | 369.17M |
| EBIT | 164.63M |
| Earnings Per Share (EPS) | $0.26 |
Balance Sheet
The company has $246.31 million in cash and $2.63 billion in debt, with a net cash position of -$2.39 billion or -$9.34 per share.
| Cash & Cash Equivalents | 246.31M |
| Total Debt | 2.63B |
| Net Cash | -2.39B |
| Net Cash Per Share | -$9.34 |
| Equity (Book Value) | 2.75B |
| Book Value Per Share | 10.77 |
| Working Capital | 281.59M |
Cash Flow
In the last 12 months, operating cash flow was $371.57 million and capital expenditures -$737.44 million, giving a free cash flow of -$365.86 million.
| Operating Cash Flow | 371.57M |
| Capital Expenditures | -737.44M |
| Depreciation & Amortization | 209.43M |
| Net Borrowing | n/a |
| Free Cash Flow | -365.86M |
| FCF Per Share | -$1.43 |
Margins
Gross margin is 50.27%, with operating and profit margins of 19.06% and 7.58%.
| Gross Margin | 50.27% |
| Operating Margin | 19.06% |
| Pretax Margin | 7.80% |
| Profit Margin | 7.58% |
| EBITDA Margin | 42.74% |
| EBIT Margin | 19.06% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 6.14%.
| Dividend Per Share | $1.20 |
| Dividend Yield | 6.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 458.84% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.18% |
| Shareholder Yield | 0.96% |
| Earnings Yield | 1.34% |
| FCF Yield | -7.32% |
Analyst Forecast
The average price target for SBRA is $22.36, which is 14.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.36 |
| Price Target Difference | 14.32% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 15.25% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |